 | Vertex Pharmaceuticals Incorpor | |||
| NMS : VRTX || Location: United States | ||||
$394.68+1.58 (+0.4%) |
0.5 M | 391.02 - 395.25 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.976 M |
| March 15, 2024 | 4.125 M |
| Feb. 29, 2024 | 4.055 M |
| Feb. 15, 2024 | 4.125 M |
| Jan. 31, 2024 | 3.307 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 4.18 | 4.20 | 0.36% |
| 09/30/2023 | 4.05 | 4.08 | 0.66% |
| 06/30/2023 | 3.96 | 3.89 | -1.75% |
| 03/31/2023 | 3.06 | 3.05 | -0.21% |
| 12/31/2022 | 3.58 | 3.76 | 4.95% |
VRTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 258.459M | Shares Float | 257.564M |
| Short Float | 3.976M | Market Cap | 101600.23M |
| Institution ownership | 97.33% | Insider ownership | 0.113% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 13.88 | Forward EPS | 18.17 |